Turkey Qualification Validation

28
GMP-Conference / 10.-11. June 2004 / Istanbul 1 Andreas Brutsche Novartis Switzerland GMP Conference, 11.06.04, Istanbul Qualification / Validation Quality Risk Assessment in the Pharmaceutical Industry - Chal lenges and Opport uni ties - Qualification / Validation Quality Risk Assessment in the Pharmaceutical Industry - Challenges and Oppor tuniti es -

Transcript of Turkey Qualification Validation

Page 1: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 1/28

GMP-Conference / 10.-11. June 2004 / Istanbul 1

Andreas Brutsche

Novartis Switzerland

GMP Conference, 11.06.04, Istanbul

Qualification / ValidationQuality Risk Assessment in the

Pharmaceutical Industry- Challenges and Opportunities -

Qualification / ValidationQuality Risk Assessment in the

Pharmaceutical Industry- Challenges and Opportunities -

Page 2: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 2/28

GMP-Conference / 10.-11. June 2004 / Istanbul 2

Qualification, Validation, Calibration

Qualification, Validation, Calibration

Visible Process

UnvalidatedProcess

New System

Validation/Qualification Iceberg

Page 3: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 3/28

GMP-Conference / 10.-11. June 2004 / Istanbul 3

Validation / Qualification Approach

User RequirementSpecifications

Functional

Specifications

Design

Specifications

System Build

Installation

Qualification

Operational

Qualificaton

PerformanceQualificationrelated to

related to

Page 4: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 4/28

GMP-Conference / 10.-11. June 2004 / Istanbul 4

Quality Risk Assessment in thePharmaceutical Industry

Quality Risk Assessment in thePharmaceutical Industry

Risk Assessment has become a key concept in thedecision making process of today’s pharmaceutical

industry. Its impact affects many disciplines including:Engineering

Manufacturing

Project Management

Quality

SafetyEnvironmental

Page 5: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 5/28

GMP-Conference / 10.-11. June 2004 / Istanbul 5

Quality Risk AssessmentQuality Risk Assessment

ProductQuality

Associated Systems

Utilities

Analytical Testing

Equipment

ManufacturingProcess

Equipment

QualificationQualification / Validation

Part 11

Water / Air / 

Process gases

Validation

Validation of the analyticalmethod

Validation

Qualification

People

Computer

Training

Page 6: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 6/28

GMP-Conference / 10.-11. June 2004 / Istanbul 6

Risk Assessment:Risk Assessment:

Each step in a process is assessed on itsinfluence on product quality.

• Critical steps have to be validated/qualified

• Uncritical steps no activities are required

Page 7: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 7/28

GMP-Conference / 10.-11. June 2004 / Istanbul 7

Equipment QualificationEquipment Qualification

• User Requirement Specifications (URS)

• Design Qualification

• Conceptual Design

• Basic Design

Detail Design• Installation Qualification

Page 8: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 8/28

GMP-Conference / 10.-11. June 2004 / Istanbul 8

Equipment QualificationEquipment Qualification

• Operational Qualification

• Performance Qualification

Calibration and Maintenance Programs

Retrospective Qualification

Page 9: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 9/28

GMP-Conference / 10.-11. June 2004 / Istanbul 9

Equipment QualificationEquipment Qualification

Design Qualification

“Defining the quality parameters required of the

equipment and manufacturer”

Page 10: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 10/28

GMP-Conference / 10.-11. June 2004 / Istanbul 10

Equipment QualificationEquipment Qualification

Installation Qualification

“Assurance that the intended equipment is

received as designed and specified.”

Page 11: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 11/28

GMP-Conference / 10.-11. June 2004 / Istanbul 11

Equipment QualificationEquipment Qualification

Operational Qualification

“Confirmation that the equipment functions as

specified and operates correctly.”

Page 12: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 12/28

GMP-Conference / 10.-11. June 2004 / Istanbul 12

Equipment QualificationEquipment Qualification

Performance Qualification

“Confirmation that the equipment consistentlycontinues to perform as required”.

Page 13: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 13/28

GMP-Conference / 10.-11. June 2004 / Istanbul 13

Validation

To prove that a process works is, in anutshell, what we mean by the verb to

validate.

E. Frey, FDA

Page 14: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 14/28

GMP-Conference / 10.-11. June 2004 / Istanbul 14

Validation

Process Validation Cleaning Validation

Computer system Validation

Validation of Analytical Methods

Part 11 Compliance

Risk based approach is key !!!

Focus on Product, not only on technology

Page 15: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 15/28

GMP-Conference / 10.-11. June 2004 / Istanbul 15

Link between Validation/ Qualification

Risk Analysis

Equipment Qualification

Risk AnalysisProcess Validation

Product

Page 16: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 16/28

GMP-Conference / 10.-11. June 2004 / Istanbul 16

Quality Risk AnalysisFlow Chart for a Solid Dosage Form Process

Quality Risk AnalysisFlow Chart for a Solid Dosage Form Process

Weigh Active Agents

Weigh Excipients Add Binder

Water / Solvent

Weigh Lubricant Add Lubricant

Solution Preparation

Weigh Excipients

Dry Mix

Wet Mix / Granulate

Dry

Dry Granulate

Blend

Compress

Coat (optional)

Page 17: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 17/28

GMP-Conference / 10.-11. June 2004 / Istanbul 17

Quality Risk AnalysisKey Parameters

Quality Risk AnalysisKey Parameters

Process Stage Parameter Worst Case Values ___________________________________________________________________________________________________________________________________________  __________________ 

Raw materials Particle size Min-Max valuesActive agent Surface areaWet mixing Binder temperature Target +/- x°C

Binder volume Min-Max used in Pilot ScaleMixing time Normal time +/- x minutes

Drying Granule moisture Upper-lower in process specBlending Granule particle size Upper-lower in process specCompression Compressor speed Normal production range

(e.g. 100000/hr-150000/hr)Pre-compression

pressure Min-MaxCoating Inlet air temperature Target + / - x

Spray rate target rate + / - x

Page 18: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 18/28

GMP-Conference / 10.-11. June 2004 / Istanbul 18

Quality Risk AnalysisCritical Process Parameter

Quality Risk AnalysisCritical Process Parameter

Parameters: Colette gral mixerAgitator - Speed 2Chopper - offMixing time - 5 minutes

Sampling After mixing take 12 samples from the mixing bowl using aRegimen: sample thief. Samples to be taken 4 top, 4 middle, 4

bottom. Sample to be 300 mg approx.

Testing: Analyse each sample for active agent content

Acceptance All individual values to be within + 7 - 10 % of the group Critmean RSD to be less than 6 %. The mean to be within

+ 7 - 5 % of the theoretical value ______________________________________________________________ 

 ______ 

Solid dosage form

Page 19: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 19/28

GMP-Conference / 10.-11. June 2004 / Istanbul 19

Tool boxRisk Assessment

Tool boxRisk Assessment

• FMEA (= Failure Mode and Effect Analysis)

• HACCP (= Hazard Analysis Critical Control Points)

• FTA (= Failure Tree Analysis)

• System Kepner-Tregoe

• Analysis of the situation

• Analysis of the problem• Analysis of the decisions

• Analysis of potential problems

Page 20: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 20/28

GMP-Conference / 10.-11. June 2004 / Istanbul 20

Tool boxRisk Assessment

Tool boxRisk Assessment

• FMEA (Failure Mode and Effect Analysis)

→ Define the “Risk Priority number” ( - RPN)

Example: Steam sterilisation Process- Steampressure / Temperature in the autoclave

- Sterilisation Time

- Measures to avoid air in the autoclave

- Treatment of the product before and after the

process

Risk 

decreasing

Page 21: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 21/28

GMP-Conference / 10.-11. June 2004 / Istanbul 21

FTA (Failure Tree Analysis)FTA (Failure Tree Analysis)

Basic

Incident 1

Basic

Incident 2

Basic

Incident 3

Basic

Incident 4

Undesired

Incident

Basic Concept:

Page 22: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 22/28

GMP-Conference / 10.-11. June 2004 / Istanbul 22

Key Success Factor:

Training and Skills of people

• Scientific skills

• Broad - Experience in pharmaceutical Industry

Leadership, Responsibilities

Risk AssessmentRisk Assessment

Page 23: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 23/28

GMP-Conference / 10.-11. June 2004 / Istanbul 23

Change / DeviationChange / Deviation

“Change” usually refers to a planned alteration which isdocumented and considered before implementation. Normally,changes are either permanent or have a fixed period of validity.

“Deviation” represents a change which may occur for a variety ofreasons during operations, or may be observed to have happenedafter the operation.

Normally, deviations are not permanent and represent single events“Planned Deviations” ??

Page 24: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 24/28

GMP-Conference / 10.-11. June 2004 / Istanbul 24

Documentation

Validation Master Plan Qualification Master Plan

GMP Risk Analysis

Validation Protocol

Test protocol (including specification)

Validation Report

Summary of Deviations / Issues

Page 25: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 25/28

GMP-Conference / 10.-11. June 2004 / Istanbul 25

Change ManagementChange Management

Who made the change

Why was the change necessary

When was the change implemented

What international consequences arise:

- Risk / benefit assessments

- Cost / benefit assessments

- Regulatory impactWho gave approvals

 _____________________________________________________________________________________________________________________________________  _____________ 

Changes are necessary - Uncontrolled changes are dangerous

Page 26: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 26/28

GMP-Conference / 10.-11. June 2004 / Istanbul 26

Computer Simulationsin Conventional Clean Rooms (Sterile Manuf.)

To be in compliance with all microbiological and particulate

requirements, the design of the sterile facilities plays themost important role.

Computer simulation studies of air flows should be used to

analyse the most critical areas.

Detailed analysis was made with regard to conflicting areas ofclass 10`000 and critical class 100 areas in order to preventany possible contamination of the product.

Detailed qualification of the balance is a prerequisite for asuccessful implementation of these design concepts.

5

Page 27: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 27/28

GMP-Conference / 10.-11. June 2004 / Istanbul 27

Initial Air Handling DesignPicture shows air inlets (units) and air exhaust systems

Loadingbuffer

Transfer cart withhorizontal laminar flow

Freezedryer 1

Freezedryer 2

Unloadingbuffer

Formattingtable

Fillingstation

Unformattingtable

Laminar flow units

Exhaust

Page 28: Turkey Qualification Validation

8/3/2019 Turkey Qualification Validation

http://slidepdf.com/reader/full/turkey-qualification-validation 28/28

GMP-Conference / 10.-11. June 2004 / Istanbul 28

Improved Air Handling DesignPicture shows new and modified air inlets (LF units) and air exhaustsystems

New exhaust

New exhaustson cart

New exhaust

Modifiedexhaust

New exhaust

New exhaust

New exhaust

New exhaust

Modifiedinlet on cart

Additional laminar flow units

Modified exhaust

New inlets (background area)